Short answer · Medically reviewed summary · Last updated: 2026-05-08
Trisomy 13 Syndrome, also known as Patau Syndrome, is a chromosomal condition characterized by the presence of an extra copy of chromosome 13 in some or all of the body's cells. The symptoms of Trisomy 13 Syndrome are typically multi-systemic, often involving severe intellectual disability, structural heart defects, and distinct physical abnormalities such as cleft lip or palate and polydactyly. What are the most common symptoms of Trisomy 13 Syndrome? The clinical presentation of Patau Syndrome is highly variable, but it frequently impacts nearly every organ system.
Trisomy 13 Syndrome, also known as Patau Syndrome, is a chromosomal condition characterized by the presence of an extra copy of chromosome 13 in some or all of the body's cells. The symptoms of Trisomy 13 Syndrome are typically multi-systemic, often involving severe intellectual disability, structural heart defects, and distinct physical abnormalities such as cleft lip or palate and polydactyly.
The clinical presentation of Patau Syndrome is highly variable, but it frequently impacts nearly every organ system. Common physical and developmental symptoms include:
The severity of Trisomy 13 Syndrome often depends on the specific type of chromosomal error. In full trisomy, where every cell has an extra chromosome 13, symptoms are typically more severe. In cases of mosaic Patau Syndrome, where only some cells carry the extra chromosome, the physical and cognitive manifestations may be milder, though clinical outcomes remain unpredictable.
Given the high frequency of cardiac and respiratory complications in Trisomy 13 Syndrome, families must seek immediate care if an infant exhibits cyanosis (bluish skin tint), difficulty breathing, or persistent feeding intolerance. These are common early warning signs of underlying structural heart or airway issues that require urgent pediatric cardiology or neonatology intervention.
In children with Patau Syndrome who survive the initial neonatal period, symptoms often shift from acute organ system management to long-term neurodevelopmental support. While many infants face significant life-limiting challenges, ongoing care often involves managing seizures, developmental therapy for motor and cognitive delays, and monitoring for persistent cardiac or renal health issues.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of a qualified healthcare provider.